171 related articles for article (PubMed ID: 31802092)
1. Modular within and between score for drug response prediction in cancer cell lines.
Wang S; Li J
Mol Omics; 2020 Feb; 16(1):31-38. PubMed ID: 31802092
[TBL] [Abstract][Full Text] [Related]
2. Network-based drug sensitivity prediction.
Ahmed KT; Park S; Jiang Q; Yeu Y; Hwang T; Zhang W
BMC Med Genomics; 2020 Dec; 13(Suppl 11):193. PubMed ID: 33371891
[TBL] [Abstract][Full Text] [Related]
3. WMMDCA: Prediction of Drug Responses by Weight-Based Modular Mapping in Cancer Cell Lines.
Wang S; Li J; Wang Y
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(6):2733-2740. PubMed ID: 32142453
[TBL] [Abstract][Full Text] [Related]
4. MSDRP: a deep learning model based on multisource data for predicting drug response.
Zhao H; Zhang X; Zhao Q; Li Y; Wang J
Bioinformatics; 2023 Sep; 39(9):. PubMed ID: 37606993
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Prediction of Cell-Line Drug Sensitivity Using Network-Based Methods.
Pouryahya M; Oh JH; Mathews JC; Belkhatir Z; Moosmüller C; Deasy JO; Tannenbaum AR
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163005
[TBL] [Abstract][Full Text] [Related]
6. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
Wang L; Li X; Zhang L; Gao Q
BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
[TBL] [Abstract][Full Text] [Related]
7. Integrating constitutive gene expression and chemoactivity: mining the NCI60 anticancer screen.
Covell DG
PLoS One; 2012; 7(10):e44631. PubMed ID: 23056181
[TBL] [Abstract][Full Text] [Related]
8. A multiple genomic data fused SF2 prediction model, signature identification, and gene regulatory network inference for personalized radiotherapy.
He QE; Tong YF; Ye Z; Gao LX; Zhang YZ; Wang L; Song K
Technol Cancer Res Treat; 2020; 19():1533033820909112. PubMed ID: 32329416
[TBL] [Abstract][Full Text] [Related]
9. Molecular Network-Based Drug Prediction in Thyroid Cancer.
Xu X; Long H; Xi B; Ji B; Li Z; Dang Y; Jiang C; Yao Y; Yang J
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641858
[TBL] [Abstract][Full Text] [Related]
10. Efficient algorithms to discover alterations with complementary functional association in cancer.
Sarto Basso R; Hochbaum DS; Vandin F
PLoS Comput Biol; 2019 May; 15(5):e1006802. PubMed ID: 31120875
[TBL] [Abstract][Full Text] [Related]
11. RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB.
Reinhold WC; Varma S; Sunshine M; Elloumi F; Ofori-Atta K; Lee S; Trepel JB; Meltzer PS; Doroshow JH; Pommier Y
Cancer Res; 2019 Jul; 79(13):3514-3524. PubMed ID: 31113817
[TBL] [Abstract][Full Text] [Related]
12. In silico perturbation of drug targets in pan-cancer analysis combining multiple networks and pathways.
Cava C; Castiglioni I
Gene; 2019 May; 698():100-106. PubMed ID: 30840853
[TBL] [Abstract][Full Text] [Related]
13. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
14. Learning the cellular activity representation based on gene regulatory networks for prediction of tumor response to drugs.
Xie X; Wang F; Wang G; Zhu W; Du X; Wang H
Artif Intell Med; 2024 Jun; 152():102864. PubMed ID: 38640702
[TBL] [Abstract][Full Text] [Related]
15. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
[TBL] [Abstract][Full Text] [Related]
16. Network Propagation Predicts Drug Synergy in Cancers.
Li H; Li T; Quang D; Guan Y
Cancer Res; 2018 Sep; 78(18):5446-5457. PubMed ID: 30054332
[TBL] [Abstract][Full Text] [Related]
17. Predicting chemosensitivity using drug perturbed gene dynamics.
Mannheimer JD; Prasad A; Gustafson DL
BMC Bioinformatics; 2021 Jan; 22(1):15. PubMed ID: 33413081
[TBL] [Abstract][Full Text] [Related]
18. Gene co-expression analysis identifies common modules related to prognosis and drug resistance in cancer cell lines.
Liu W; Li L; Li W
Int J Cancer; 2014 Dec; 135(12):2795-803. PubMed ID: 24771271
[TBL] [Abstract][Full Text] [Related]
19. Optimal control nodes in disease-perturbed networks as targets for combination therapy.
Hu Y; Chen CH; Ding YY; Wen X; Wang B; Gao L; Tan K
Nat Commun; 2019 May; 10(1):2180. PubMed ID: 31097707
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of genotype-specific drug responses in cancer.
Kim N; He N; Kim C; Zhang F; Lu Y; Yu Q; Stemke-Hale K; Greshock J; Wooster R; Yoon S; Mills GB
Int J Cancer; 2012 Nov; 131(10):2456-64. PubMed ID: 22422301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
